Cyclacel Pharmaceuticals, Inc. - Neraca (Quarterly)

Cyclacel Pharmaceuticals, Inc.

Talaan ng Balanse (Quarterly)

Neraca Cyclacel Pharmaceuticals, Inc. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 23 33 48 44 40 37 30 29 24 18 11 10 6 3 3 6 3 3 3 4
Change (%) 44.43 43.02 -8.66 -7.84 -9.10 -18.93 -1.90 -18.47 -22.61 -37.67 -11.11 -41.52 -43.17 -17.17 114.44 -50.30 5.20 9.98 23.91
Assets Current 26 35 50 46 43 41 37 32 28 24 19 15 11 7 5 8 5 4 4 4
Change (%) 36.77 42.27 -8.44 -6.12 -5.61 -10.66 -12.30 -12.98 -12.55 -22.27 -19.39 -27.34 -33.02 -35.05 59.40 -36.25 -25.22 1.09 18.01
Assets 27 37 52 46 45 43 40 35 31 28 22 16 12 9 6 8 5 4 4 4
Change (%) 35.24 40.80 -10.58 -2.88 -4.14 -8.13 -10.81 -12.24 -9.58 -21.35 -25.47 -23.99 -29.54 -29.98 32.85 -34.30 -23.92 -8.79 17.86
Liabilities 3 4 4 3 4 5 6 5 9 12 12 11 8 8 8 7 6 6 1 1
Change (%) 27.68 6.35 -17.25 16.58 49.74 14.26 -17.37 74.24 35.26 -1.64 -5.09 -27.47 -0.02 2.11 -14.10 -11.68 -1.31 -89.28 14.58
Equity 24 33 48 43 41 38 33 30 22 16 10 5 4 1 -2 1 -1 -2 3 4
Change (%) 36.10 44.47 -10.06 -4.29 -8.87 -11.36 -9.59 -26.95 -27.77 -36.33 -49.39 -16.34 -85.87 -463.43 -145.29 -197.10 124.12 -240.85 18.58
Liabilities And Stock Equity 27 37 52 46 45 43 40 35 31 28 22 16 12 9 6 8 5 4 4 4
Change (%) 35.24 40.80 -10.58 -2.88 -4.14 -8.13 -10.81 -12.24 -9.58 -21.35 -25.47 -23.99 -29.54 -29.98 32.85 -34.30 -23.92 -8.79 17.86

Source: Capital IQ

Other Listings
DE:UXI1
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista